Vasoactive Intestinal Peptide (VIP) in COVID-19 Therapy-Shedding of ACE2 and TMPRSS2 via ADAM10. [PDF]
Gutzler C +11 more
europepmc +1 more source
Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes. [PDF]
Hou X +7 more
europepmc +1 more source
Carcinoid heart findings in vasoactive intestinal peptide-secreting tumour. [PDF]
Joshi M, Aldea D, Ngo P, Shah S.
europepmc +1 more source
Changes in TRPV1 Expression as Well as Substance P and Vasoactive Intestinal Peptide Levels Are Associated with Recurrence of Pterygium. [PDF]
İlhan HD, Ünal B, Ayaz Y, Erin N.
europepmc +1 more source
Vasoactive intestinal peptide reduces ocular hypertension by regulating tight junction of trabecular meshwork through Rab13/PKA signalling complex. [PDF]
Chen L, Yan X, Luo Z, Cheng Y, Li M.
europepmc +1 more source
Vasoactive Intestinal Peptide-Secreting Pancreatic Neuroendocrine Tumor: A Case Report. [PDF]
Thivacaren S +3 more
europepmc +1 more source
Vasoactive Intestinal Peptide (VIP) Protects Nile Tilapia (Oreochromis niloticus) against Streptococcus agalatiae Infection. [PDF]
Zhang Z +7 more
europepmc +1 more source
Vasoactive intestinal peptide blockade suppresses tumor growth by regulating macrophage polarization and function in CT26 tumor-bearing mice. [PDF]
Kittikulsuth W +8 more
europepmc +1 more source
Circadian regulation of cardiovascular function: a role for vasoactive intestinal peptide.
A. Schroeder +4 more
semanticscholar +1 more source

